The Management of Polycystic Ovary Syndrome in Adolescents with Obesity Authors: Thomas M Barber, Puja Thadani, Elizabeth V Niven, Ioannis Kyrou, Harpal S Randeva Published: 2026 ABSTRACT AbstractAdolescence marks a transition between childhood and adulthood, a time of change and turbulence in which the hypothalamo-pituitary gonadal (HPG) axis activates, acting as a harbinger for the development of secondary sexual characteristics, thelarche and menarche in girls, growth and development of bone and skeletal muscle, psychosocial and identity development. Contemporaneous with these changes, adolescence coincides with heightened peer pressure to conform to social norms, academic pressure, and impending exams. This rite of passage into adulthood is like a white-water ride, at a time when the brain is still in development (with compromised ability to make rational and sensible decisions due to relative immaturity of the frontal lobes). To accommodate increased nutritional needs, there is enhanced appetite during adolescence. In the context of our modern-day obesogenic environment with an abundance of cheap (and often addictive) ultra-processed foods, weight gain is common. In adolescent girls, weight gain and the development of obesity can result in the clinical manifestation of polycystic ovary syndrome (PCOS), in those with a genetic predisposition. Our management approach to this challenging subgroup of patients needs to adopt holism and compassion. Mental health problems (including covert bullying in virtual spaces, hidden from adult view and management) are common and not always openly expressed. These require effective and timely management from appropriately trained healthcare professionals. Effective and sustained weight loss, including the adoption of healthy lifestyle behaviours (including improved diet), remains key. However, challenges exist that include age restrictions to pharmacotherapies and bariatric surgical approaches for obesity management. Furthermore, adolescence seems marginalized in healthcare settings (with notable exceptions). We need to prioritize adolescence in our future healthcare provision and infrastructure development, including proactivity for the future secondary school. Moreover, we need environmental and cultural change and reform.Keywords: Obesity, Adolescence, Polycystic ovary syndrome Key Summary Points Adolescence is inherently vulnerable, and coincides with the physiological, psychosocial, emotional and sexual development of puberty, heightened peer pressure to conform, and academic demands.With the activation of the hypothalamo-pituitary gonadal (HPG) axis coinciding with growth and development, enhanced appetite and caloric ingestion and propensity for adiposity, polycystic ovary syndrome (PCOS) often becomes manifest during adolescence.Given the importance of insulin resistance in the pathogenesis of PCOS, effective weight loss is a key focus. However, we are limited in our current options for pharmacotherapeutic and surgical approaches to obesity management in adolescence. This is coupled with marginalization of healthcare infrastructure and provision for adolescents more generally.Novel molecules in development that improve insulin sensitization and that reduce adiposity whilst preserving skeletal muscle mass and function and optimizing body composition hold potential for the future management of PCOS in adolescents with obesity.The ‘future school’ is important for the holistic nurture of children, catering for both their educational and healthcare needs. This includes school-based environmental reform (with a focus on healthy eating and physical activity), a focus on healthy lifestyle behaviours, and the instilment of a more compassionate approach to obesity and other health-related problems. Introduction Polycystic ovary syndrome (PCOS) is a common endocrine condition that affects between 6% and 10% of reproductive-age women [1–4]. The clinical manifestations of PCOS straddle two main domains [5]. These include hyperandrogenic features (hirsutism, acne, and male-pattern alopecia) and reproductive problems (sub-fertility, impaired ovulation, and oligoamenorrhoea) [6]. PCOS is a diagnosis of exclusion. Given the susceptibility of the female reproductive axis to aberrant functioning (in the context of conditions such as congenital adrenal hyperplasia, hyperprolactinaemia, adrenal tumours, and underweight), it is important to exclude other conditions that can mimic the clinical features of PCOS prior to making this diagnosis. Beyond its diagnostic clinical features, PCOS is also typified by characteristic biochemical and radiological features, including elevations in serum levels of androgens and polycystic ovarian morphology [7]. Furthermore, although not essential for its diagnosis, PCOS also associates with metabolic dysfunction [including type 2 diabetes (T2D) and obstructive sleep apnoea (OSA)], with pathophysiological unification from insulin resistance [8, 9]. Although multiple diagnostic criteria exist, we define PCOS by the ‘Rotterdam’ criteria that require (with exclusion of other aetiologies) the presence of at least two out of three of the following features: (i) oligo- and/or anovulation; (ii) clinical and/or biochemical signs of hyperandrogenism; (iii) polycystic ovaries [5]. In the context of adolescent girls, there are challenges that include difficulties with imaging the ovaries, and the interpretation of endocrine tests relating to the gonadal axis (that may still be in a state of transition during puberty). Furthermore, menstrual irregularity is normal during puberty (and can take between 1 and 3 years before menstrual cycles become regular) [10], further challenging a diagnosis of PCOS during adolescence, given that menstrual irregularity forms a key diagnostic criterion. In addition to its association with metabolic dysfunction, PCOS usually coexists with obesity. Epidemiological data reveal that overweight or obesity affects between 38% and 88% of women with PCOS [11–13]. Furthermore, a meta-analysis showed that women with obesity are 2.77-fold more likely to develop PCOS than lean women [14]. There is corroboration of the epidemiological evidence for the contemporaneous manifestations of female obesity and PCOS from genetic studies, including those that reveal association of gene variants that influence fat mass (including variants within FTO) and the development of PCOS [15–20]. Furthermore, a meta-analysis of genome-wide data on PCOS revealed a shared genetic architecture between obesity and PCOS [21], contributing towards the heritability of PCOS [22]. The frequent coexistence of obesity with PCOS is no coincidence. Rather, obesity and its association with insulin resistance and compensatory hyperinsulinaemia form important components of the underlying pathophysiology of PCOS. As such, weight gain and the development of obesity in women serves as a risk factor for the development of PCOS. Besides PCOS, there are more than 50 conditions that associate with obesity (spanning metabolic, psychiatric, biomechanical, and oncological domains). These conditions form a major part of modern-day chronic disease, most notably T2D, and contribute towards substantial global morbidity, mortality, and socio-economic burden [13, 23, 24]. For each of these obesity-related conditions, obesity only serves as a risk factor for their development, rather than their development being an inevitability. Our underlying genetic architecture influences our individual propensity for developing any obesity-related condition in the context of weight gain and obesity. PCOS is no exception to this rule. PCOS manifests in those with a genetic predisposition to its development [25–28], often in the context of weight gain and obesity. Unfortunately, the last 40 years has borne witness to a global surge of female obesity, with rates having increased 2.5-fold from 6% to 15% [29]. In its wake, this has driven the development and high prevalence of obesity-related conditions, including PCOS. Although it can manifest at any stage of reproductive life in women, PCOS commonly develops in girls during adolescence [13]. In this brief review, we discuss the vulnerability of adolescence from the perspective of the hypothalamo-pituitary gonadal (HPG) axis, propensity for weight gain, and inherent academic and social pressures. We then discuss the principles of management of PCOS in adolescent girls with obesity, including a focus on healthy lifestyle, weight loss, hyperandrogenic, reproductive, and mental health problems. Finally, we imagine a future scenario that merges the school with effective healthcare for adolescents and use PCOS as an exemplar. Throughout, we need to be mindful that our discussion spans three separate components: (i) obesity; (ii) PCOS; (iii) adolescence. Each of these components has its individual needs and demands. The key to effective management of PCOS in adolescent girls with obesity requires us to conflate these three components into holism, in which the patient is managed as a person [22]—a conflation that promotes transformation of our future management of this challenging clinical scenario. Methodology We performed a narrative review of the current literature and used Pubmed for this purpose. The search terms included ‘polycystic ovary syndrome’, ‘adolescence’, and ‘obesity’. We only considered articles written in English. There were no restrictions on the date of publication. As a result of limitations of the permitted number of references, we used our discretion in citing the most relevant and clinically meaningful papers within the current literature. This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors. The Vulnerability of Adolescence Adolescence is a time of change and marks a transitional period between childhood and adulthood. Such change occurs across multiple levels, including physiology, brain development (primarily ‘pruning’ of diverse neuronal synapses) [30], endocrinology (such as the development of the gonadal axis), psychosocial and identity development. Contemporaneous with these diverse transitions, adolescence often also coincides with academic pressures and a heightening of peer pressure to conform to social norms. This in turn can result in bullying and mental health problems (in our modern era, such bullying often occurs via digital means and may be enacted covertly). Adolescence usually coincides with attendance at secondary school, and as such there is much potential and opportunity for the secondary school of the future to play a more proactive role in addressing the lifestyle, healthcare, and wellbeing needs of adolescents. The transitional quiddity of adolescence, combined with its status as a gateway into (or harbinger of) adulthood, places adolescence as an inherently vulnerable period in any young person’s life. Despite this inherent vulnerability, adolescence seems somewhat neglected in our modern-day western health infrastructure [31]. One example of such neglect includes a relatively common scenario within the UK-based NHS healthcare setting in which children’s medical services (such as obesity) often apply up to 16 years, and yet adulthood services often start from age 18 years. This leaves a hiatus between the ages of 16 and 18 years with the provision of limited specialist support, at a time when healthcare needs are often prominent, and should be prioritized by healthcare services. This disconnect between our current provision of healthcare services and the level of age-based needs for healthcare provision should be addressed in the future redesign of healthcare administration. In this section, we provide a brief overview of the vulnerability of adolescence, particularly relevant for adolescent girls living with obesity and PCOS (summarized in Fig. 1). The vulnerability of adolescence. HPG hypothalamo-pituitary gonadal, PCOS polycystic ovary syndrome, UPF ultra-processed food Activation of the HPG Axis Of all the features that typify adolescence, none is more important than puberty. It could even be stated that puberty is the quintessence of adolescence, and the two are so interlinked as to be almost synonymous. Puberty marks the physiological and endocrinological transition from childhood into adulthood. Rather than a switch, this is a gradual process in both boys and girls, and manifests over a period of years. Characterized by sex-specific changes in body composition and the development of secondary sexual characteristics such as pubic hair, puberty is driven by key hormonal changes. Essentially, puberty is an announcement of the activation of the HPG axis: a transition from its quiescent childhood status into an active and (in the case of girls) pulsatile entity that will remain active and pulsatile until menopause. (Of course, the status of the HPG axis may change during pregnancy, lactation, weight gain or loss, chronic illness, and through use of the oral contraceptive pill.) In girls, a key feature of puberty is menarche, the onset of menses. It is beyond the scope of this concise review to provide a detailed exposition of the molecular and endocrine basis for puberty, which was reviewed recently [32]. Although the precise trigger for puberty remains incompletely understood, we have made much progress in our understanding of the neuroendocrine basis for puberty in recent years. This includes the discovery of kisspeptin and its role in the hypothalamic activation of the HPG axis [32, 33]. The timing of puberty is influenced by genetic factors, but also by environmental cues (including nutritional status) [32], and even epigenetics [34]. The timing of puberty in girls has varied historically. During the Industrial Revolution (eighteenth–nineteenth centuries), menarche occurred as late as 16–18 years [35]. This delay in menses is usually attributed to malnutrition, overcrowding, and poor hygiene [35]. Since then, there has been a secular trend for the age of menarche, which has dropped to its current level of 12–12.5 years old [36]. Interestingly, in the prehistoric era (Paleolithic and Neolithic eras), skeletal remains reveal early menarche, between 7 and 13 years, probably driven by high mortality and the need for early reproduction [37]. Combined with the secular trend in the timing of menarche, girls typically enter puberty around 1–2 years before boys, with physical changes (including thelarche) occurring around 10–11 years [38]. Weight Gain The global obesity problem is as relevant for children and adolescents as it is for adults. Globally, the overall prevalence of obesity in children and adolescents is 8.5% (ranging between 0.4% and 28.4%, with higher rates in high-income countries), based on data from nearly 46 million children and adolescents living in 154 countries [39]. Excessive body weight affects more than 20% of children and adolescents [39]. In addition to the metabolic problems that adolescent obesity underlies, the presence of adolescent obesity acts like an unwelcome harbinger of obesity in adulthood, with around 80% of adolescents with obesity also living with obesity as adults (a fivefold increased risk of adulthood obesity compared with lean adolescents) [40]. Adolescence is a vulnerable period for body weight. Puberty coincides with a surge of appetite (starting around the age of 10 years for girls), and this can often cause intense hunger [41]. This appetite surge is driven from the nutritional needs of the body which undergoes rapid growth and physical changes (including the growth of bones and muscles) [41]. This intense hunger can result in the overconsumption of calories that over time can result in weight gain and the development of obesity. The vulnerability of adolescence is heightened by our modern-day obesogenic environment, and particularly our unhealthy food environment with an abundance of cheap (and often addictive) ultra-processed foods (UPFs) and a relative lack of affordable healthy food options that are replete with essential fibre and micronutrients [42]. The interlinks between puberty, enhanced appetite, weight gain, and obesity are further complicated by mechanisms whereby obesity can impact on the timing of puberty. Recent evidence reveals that obesity-induced neuroinflammatory changes within the hypothalamus may cause premature activation of the HPG axis through effects on the gonadotrophin-releasing hormone (GnRH) neurons. This can manifest in precocious puberty [43]. The impact of obesity on the timing of puberty implicates the involvement of hypothalamic microglial cells and phoenixin action, and obesity-induced changes in neuronal metabolic regulation [43]. Excess adiposity beginning in childhood confers an independent risk of PCOS beyond the contribution of adult body weight. In a systematic review and analysis incorporating Mendelian randomization (MR), PCOS odds were higher in adolescents with overweight (OR 5.32, 95% CI 2.99–9.45) and obesity (OR 7.86, 95% CI 3.09–19.96), and effect sizes exceeding those seen in adult women [44]. Importantly, MR analysis showed that genetically determined childhood body size increased PCOS odds independently of adult body size (OR 2.56, 95% CI 1.57–4.20), providing causal evidence that early life factors exert a direct pathophysiological influence on the development of PCOS [44]. The ‘Northern Finland Birth Cohort (1996)’ also demonstrated that an earlier age of adiposity rebound independently associated with PCOS in adulthood (OR 1.62, 95% CI 1.37–1.92) [45]. Furthermore, data from the ‘Copenhagen School Health Records Register’ (> 65,000 girls) showed that childhood overweight associated with a nearly threefold increased hazard of PCOS development (HR 2.83 at age 7 years), with cumulative duration of excess weight amplifying this risk in a dose-dependent manner [46]. Childhood obesity promotes the development of PCOS through metabolic pathways. Excessive adiposity drives insulin resistance and hyperinsulinaemia, with suppressed hepatic sex hormone binding globulin (SHBG) production and augmented ovarian androgen production [44, 47]. Genetically determined fasting serum insulin level is amongst the strongest of predictors for the development of PCOS (OR 0.74 per 28 nmol/L increase in fasting serum insulin level, 95% CI 0.64–0.87) [44]. Notably, lean mass did not associate with PCOS risk, promoting fat mass as a biologically active contributor to the risk of PCOS development [44]. Finally, analysis of ‘two-cohort data’ showed that the development of PCOS in adolescent girls is preceded consistently by a marked increase in body weight from birth, suggesting that the accrual of postnatal fat tissue may initiate the hormonal cascade culminating in the clinical manifestation of PCOS [48]. Collectively, these data highlight the importance of prevention, and timely identification and effective management of obesity in children and adolescents. Academic and Social Pressures As outlined, adolescence often coincides with heightened academic pressures in the context of a secondary school setting. The need to attain academic qualifications (including in the core subjects of language/English and mathematics) acts like a prerequisite and gateway into our transition from childhood to the adult world of work, jobs, and careers. Understandably, such academic pressures can contribute towards mental health problems including anxiety, especially during the time of exams and their build-up. In our modern-day world, academic pressure on children is coupled with anxieties around future job prospects and student loans, pressure from parents and other carers, and peer pressure. The current generation of adolescents seem particularly prone to anxiety and other mental health problems, possibly attributed to the use of social media, and electronic devices with forward-facing cameras (that enable the taking and distribution of ‘selfies’) [49]. Coupled with academic pressures, adolescence is also typified by heightened social pressures. This includes the development of personal identity and social norms. The need to conform with peers often looms large on adolescents and can contribute towards anxiety and other mental health problems, especially for those who have traits that may deviate from the norm. Bullying behaviour is relatively common in adolescence. With the current prominence of electronic devices and social media, this has created a new arena in which adolescents interact within the virtual world. A virtual world that is hard to police and regulate, and one that has potential for intrusiveness and covert behaviours that are hidden from the view of adults. The emergence of this murky new world at the dawn of our current information revolution serves to heighten the social pressures on adolescents, and the potential for bullying and ill-being. A key challenge for the future is to address the negative impact that our unprecedented modern-day digitally connected world has on adolescents, and to protect them from any unnecessary social pressures and manipulation. To summarize this section, adolescence marks a key transition from childhood to adulthood. This transition manifests across multiple domains. These include the physiological (including physical, psychosocial, emotional, and sexual) changes of puberty with its activation of the HPG axis, increased demand for nutrients with enhanced appetite and food intake and a propensity for weight gain and obesity, heightened social pressures to conform (with the additional complications of social media, digital connections, and the potential for covert bullying and manipulation and associated stress and anxiety), the development of adult identity, and academic pressures with the stress of exams and future career and job prospects. These multiple domains need to be navigated at a time when brain development is a work in progress, and when the frontal lobes (essential for executive function and inhibiting impulsiveness) are under-developed [50]. If a person’s life can be likened to the course of a river, adolescence could be represented by white water rapids, a period of turbulence, transition, change, and preparedness for the adult (often calmer) river ahead. It is a time when the upstream tributaries of childhood converge into one steep and narrow track, riddled with boulders. Adolescence is inherently a period of vulnerability and turmoil. Our management approach (used here in its holistic sense) to adolescence needs to adapt accordingly. In short, we need to align our approach to the white-water rapid ride of which our adolescent patients are in the midst. Principles of Management of Adolescents with Obesity and PCOS As outlined, there are close interlinks between female adolescence, weight gain and obesity, and PCOS. Our management approach needs to align accordingly. In this section, we discuss the principles of management of adolescents with obesity and PCOS. We focus our discussion around two key domains: (i) obesity; (ii) clinical features of PCOS. Firstly though, it is important to recognize that this challenging clinical scenario often coexists with mental health and psychosocial problems, affecting emotional regulation and peer relationships [51]. The management approach to this scenario has been reviewed recently [52]. For all healthcare professionals (HCPs) involved in the management of PCOS in adolescent girls with obesity, we need to always consider concurrent mental health problems that may be hidden from our view and require effective and timely management approaches, delivered with compassion. Management of Obesity Obesity is a key driver for insulin resistance and the clinical manifestation of PCOS. As such, effective weight loss is an important management strategy. Beyond improvement of the clinical features of PCOS, effective weight loss would also optimize future metabolic outlook, and reduce the likelihood of adult obesity [53]. However, enabling effective weight loss during adolescence is challenging. Here, we provide a brief overview of lifestyle, pharmacotherapies, and bariatric surgery. Lifestyle Management The consumption of nutrient-dense foods is necessary for adolescents, and there is a clear need for focused nutritional and dietary support, at a time when this is typically lacking in our current healthcare and schooling infrastructures. Where possible, caloric restriction with negative energy balance and lower glycemic carbohydrates should be encouraged [54]. It is also important to address any deficit in dietary fibre [55]. Whatever dietary approach we take, we need cognizance that adolescence coincides with a surge of appetite. In our obesogenic environment, with an abundance of cheap and unhealthy (and often addictive) UPFs, this creates a particular problem during adolescence. To use our river analogy, our modern-day food environment is redolent of placing more boulders in the riverbed to increase its turbulence. We can provide dietary and healthy lifestyle advice to adolescents and their parents (including advice on physical activity and sleep sufficiency), but what is really needed is for us to make radical changes to the riverbed, to remove those unnecessary boulders that create additional turbulence: to transform our food environment towards healthy and affordable options, and to modify other aspects of our environment (including physical and cultural elements) to facilitate and encourage a healthy lifestyle, and a smoother and less turbulent transition into adulthood. Anything other than effective environmental change is merely a ‘sticking plaster’ approach: we need to remove the boulders rather than just throw our adolescents a bigger (and ineffective) paddle. Pharmacotherapies In recent times, there has been unprecedented interest in the weight-loss potential of therapies based on glucagon like peptide 1 (GLP1), with more than 200 biotechnology companies globally interested in the obesity pharmacotherapy market. Over the coming years, we will see multiple novel classes of therapies, including non-peptidic (glipron) forms of GLP1 that can be taken orally. In one study on women with obesity and PCOS (mean age 30 years) who were unresponsive to a prior lifestyle plan, the use of semaglutide (a GLP1 receptor agonist) at a low dose over 3 months resulted in ≥ 5% reduction in body weight in around 80% of the participants, with normalized menstrual cycles in 80% of responders [56]. In a meta-analysis of randomized controlled trials (RCTs) that explored the use of GLP1 therapies (semaglutide and liraglutide) in (n = 176) women with obesity and PCOS, compared with placebo there was a significant reduction of body mass index (BMI) (− 2.42 kg/m2) with GLP1, and significant reductions in serum triglycerides and total testosterone [57]. Currently, tirzepatide (Mounjaro, a GLP1 and glucose-dependent insulinotropic polypeptide [GIP] dual agonist) is only licensed for adults > 18 years old. Likewise, semaglutide (Wegovy) is also only licensed in adults > 18 years old, although in regions such as the European Union, it is also approved for adolescents aged 12–17 years with obesity. There is a relative lack of data for the efficacy of GLP1 therapies in adolescents. However, in recent times we have seen the emergence of such data. Notably, recently reported RCTs on adolescents with obesity randomized to placebo versus daily liraglutide (3 mg) [58] and weekly semaglutide (2.4 mg) [59], each combined with lifestyle management, revealed significantly greater reductions in BMI in the treatment arms of each. However, despite these reported studies, and the occasional extension of licensing for the use of GLP1 therapies in adolescents with obesity, there are significant challenges to the widespread adoption of pharmacotherapies to adolescent girls with obesity and PCOS. These include a lack of sufficient funding and healthcare infrastructure to support such an approach, potential tolerability issues (such as upper gastrointestinal side effects), and concern of weight regain following discontinuation of GLP1-based therapies [60]. Bariatric Surgery There are limited reports of the efficacy of bariatric surgery in PCOS. In one reported study from China, sleeve gastrectomy was performed on women aged 18–40 years with confirmed PCOS and a BMI ≥ 27.5 kg/m2 [61]. At 12 months follow-up, there was complete remission of PCOS (with 6 consecutive menstrual cycles or spontaneous pregnancy) in 78% with a median BMI of 23.7 kg/m2 [61]. In one study that reported on more than 1500 women who had undergone bariatric surgery, PCOS had been diagnosed in 13.1% of the participants, and the mean age for the procedure was 44.8 years (range 18–78 years) [62]. Bariatric surgery is an effective therapy for obesity, with potential to improve the clinical features of PCOS. However, this approach will never be scalable to the population level. Furthermore, bariatric surgery is rarely considered for adolescents and children (as evidenced by a lack of data for children and adolescents reported in the literature). As such, in its current form, bariatric surgery is essentially off-limits for the adolescent girl with obesity and PCOS. It will be important to explore the future implementation of minimally invasive endoscopic innovations in this patient cohort though, including for example, duodenal resurfacing, gastric balloons, endo-barrier, and endoscopic gastroplasty [63, 64]. Management of the Clinical Features of PCOS In the clinical context of adolescent girls with obesity and PCOS, the clinical features of PCOS requiring management encompass two broad domains: those relating to hyperandrogenism, and menstrual disturbance. It is beyond the scope of our concise review to provide a detailed discussion. Rather, here we provide an overview of salient points. Hyperandrogenism By definition, hyperandrogenism refers to any of the clinical manifestations of raised serum androgens that typify PCOS. Broadly, these include androgenic alopecia, acne, and hirsutism. In the context of adolescent girls, although acne (even in those without PCOS and obesity) is relatively common, hirsutism (sometimes referred to as the ‘thief of womanhood’) remains the main concern [8]. As with other aspects of PCOS, first-line interventions include healthy lifestyle changes and effective and sustained weight loss (outlined in the last section) [65]. Hormonal therapies such as the combined oral contraceptive pill (cOCP) should be considered, although this needs to be balanced with increased risk of thromboembolism (TE), discussed below. Metformin remains an option (although this is off license) [65]. When these modes of therapy either fail or are contraindicated, anti-androgens (such as spironolactone and flutamide) can be considered [65]. However, these therapies have teratogenic effects and so always need to be used with barrier contraception for sexually active female patients. Furthermore, flutamide can cause hepatotoxicity [65]. Across all anti-androgen agents, there is low-quality evidence in adolescents, and adequately powered adolescent-specific RCTs are needed. A critical practical consideration is that none of the anti-androgen agents studied carries a regulatory license specifically for the treatment of hyperandrogenism, and their use in adolescence is entirely off label. For these reasons, anti-androgens are less commonly used in adolescent patients. Beyond effective lifestyle changes, weight loss, metformin, and anti-androgens, there is laser hair removal and electrolysis, as a more permanent and effective treatment, often considered following medical management of hyperandrogenaemia. Age restrictions do vary according to clinic, but in most cases these hair removal options are available to adolescent girls, with parental consent and presence of parent or legal guardian at the time of the treatment. Our therapeutic options for hyperandrogenic features in adolescent PCOS have been static for decades, with an important unmet need for effective therapies without any associated safety concerns. A challenge for the future is to develop novel therapies for women and girls with PCOS that improve and resolve its clinical features, and that target the key pathophysiology of this condition in a safe and effective manner. Menstrual Disturbance In PCOS, oligo-anovulation results in menstrual disturbance. Broadly, our management approach focuses on fertility and the impact of menstrual disturbance on wellbeing and quality of life. As mentioned, effective weight loss through the strategies outlined above forms a key management approach. In the context of adolescent girls with obesity, although fertility treatments are not applicable, we still need to consider and optimize their future fertility potential through effective weight loss [66]. Furthermore, the potential impact of PCOS on their future fertility may cause anxiety, and this needs to be addressed with compassion and understanding. In addition to weight loss, we need to consider other management approaches for menstrual disturbance and its impact on wellbeing in adolescent girls with obesity and PCOS [66]. One option would be through existing hormonal therapies such as the cOCP or progesterone-based therapies. Regarding estrogen-based therapies (including cOCP), these are known to increase the risk of TE [67, 68]. In adolescents, TE is often multifactorial, although obesity is a major risk factor [69]. Furthermore, PCOS is also a risk factor for TE, independent of obesity [70]. In the clinical context of adolescent girls with obesity and PCOS, there is a double-whammy increased risk of TE from obesity and PCOS. The addition of estrogen-based therapies is a triple-whammy increased risk of TE. Beyond obesity and PCOS, we need detailed evaluation for all risk factors for TE prior to any consideration of estrogen-based therapies in this vulnerable patient group [69]. To avoid any increased risk of TE, menstrual disturbance can be managed through progesterone-only options, such as drospirenone, desogestrel, or levonorgestrel [71]. Beyond lifestyle and pharmacotherapeutic strategies, it is important to recognize that adolescent girls living with obesity and PCOS often experience distress, and there is a heightened risk of developing psychiatric problems such as depression and anxiety [72]. Therefore, the management options outlined above need to be complemented with focused psychological support (where necessary) and the availability and provision of psychiatric support from adolescent mental health teams. Conclusions and Future Management Approaches Adolescence marks a time of transition in which the memories, experiences, and learnings of one’s past childhood converge on the hopes, expectations, and anxieties of one’s future adulthood. Adolescence is inherently vulnerable, and coincides with the physiological, psychosocial, emotional and sexual development of puberty, heightened peer-pressure to conform, and academic demands. Coupled with this maelstrom, adolescence is often neglected within healthcare infrastructures, eclipsed typically by a focus on services that cater for children and adults. This is unfortunate given that many conditions (including PCOS) often become manifest during adolescence. Rather than marginalizing adolescence in our current healthcare models, we should arguably promote novel healthcare infrastructure and strategies to cater for the unique healthcare needs and demands of adolescents. Although there are some commendable examples of this within the current NHS-based setting in the UK (including in the context of mental health in some localities), we need to broaden our approach towards healthcare provision that caters more holistically for the complex and bespoke needs of adolescents. In this concise review, we have outlined the vulnerability of adolescence, and the main principles of management of PCOS in this context, that straddle obesity, hyperandrogenic and menstrual disorders, and mental health problems. Given a central role of insulin resistance in the pathogenesis of PCOS, future treatment options should focus on improving insulin sensitivity [73]. In this regard, it would be interesting to explore the therapeutic potential of second-generation insulin sensitizers in PCOS [74]. These therapies inhibit the delivery of pyruvate to mitochondria, and through changes in cellular nutrient handling, can improve glucose and lipid profiles, but also reduce serum levels of insulin (through improved insulin sensitivity) [74]. As such, there is potential to alleviate the co-gonadotropic effects of hyperinsulinaemia (including hyperandrogenic features and ovulatory potential) in PCOS [22]. Importantly, these novel therapies lack the undesirable adverse effects of first-generation insulin sensitizers [peroxisome proliferator gamma (PPARγ) agonists such as pioglitazone], such as fluid retention and reduced bone density [75]. Beyond the optimization of insulin sensitivity, the future management of PCOS in adolescent girls with obesity will likely utilize novel pharmacotherapies that induce a reduction of adiposity whilst preserving skeletal muscle (SM) mass, thereby optimizing body composition. This strategy would be particularly effective in PCOS given the favourable metabolic implications (including insulin sensitivity) of preserved SM mass and function [76]. Unlike the GLP1-based therapies that induce a ‘negative energy balance’ through reduced caloric intake (with inevitable decline in SM mass), the metabolic accelerators such as HU6 (a prodrug for 2,4-dinitrophenol) act to enhance energy expenditure, thereby preserving SM mass and function whilst inducing a reduction of adiposity [77]. As such, novel molecules such as HU6 have potential therapeutic utility in the context of PCOS in adolescent girls with obesity. Moreover, the future management of adolescent girls living with PCOS and obesity demands a holistic and compassionate approach. Beyond novel pharmacotherapies, we need to consider how we can improve healthy lifestyle choices for adolescents, thereby mitigating against excessive weight gain and the development of obesity. One opportunity is for our future schools to adopt proactivity in the healthcare needs of adolescents. Most adolescents attend secondary school. Traditionally, the purpose of school is for educational provision. In our highly democratized society, we partition the educational and healthcare needs of our children and adolescents into silos. Recently, we published an overview of our vision for the future school, in which rather than being immiscible, we envision a conflation of education and healthcare, in which both the educational and health (both physical and mental) needs of our children and adolescents are addressed within the future school setting [78]. This will require us to modify our notion of school, and for the physical and cultural features of the future school to be redesigned accordingly [78]. Our vision will also require a new breed of HCP, trained specifically to manage the healthcare needs of children and adolescents, who are based not in traditional healthcare settings such as hospitals but in our schools [78]. Such HCPs would address all health needs including, for example, diet, lifestyle, infections, and chronic illness. Furthermore, mental health problems within our children and adolescents could be dealt with at source, with a more proactive approach to the elicitation and effective management of such problems prior to any crisis occurring [78]. (There have been some tragic cases reported in the national media in recent times.) This approach is particularly relevant in our modern-day society with its emphasis on social media and virtual interactions and potential for covert bullying. Our model for the future school would also alleviate pressure on hospitals and primary care (e.g. GP surgeries), through addressing emergent healthcare problems early within the school environment [78]. Of course, such a model would not replace the need for hospital-based care and management of children and adolescents when needed, but this demand on traditional healthcare provision would likely be alleviated. Through focusing on pupils attending school, such an approach would help to address the current unmet need of a lack of funding and infrastructure for effective adolescent healthcare. The example of adolescent girls living with PCOS and obesity aligns itself particularly well to our model for the future school. With greater emphasis on healthy lifestyles and environmental reform (including the school food environment, for example), this would help in the effective management of obesity, including the prevention of excessive weight gain in adolescents, thereby reducing the risk of developing PCOS. As with all obesity-related conditions, effective treatment and prevention of obesity remains a key focus for the future management of PCOS, particularly in the context of adolescent girls. Our current society seems to place excessive emphasis on the individual when it comes to weight gain and obesity. This misconception breeds misunderstanding, blame, and a dispassionate perspective, with misattribution of obesity to human vices such as sloth and greed [79]. These pernicious mindsets (that often become entrenched during adolescence) only serve to worsen the traumatic experiences of adolescent girls, newly living with PCOS and obesity. As such, they would demotivate the successful adoption of healthy lifestyles [79]. In the future, as a society we need to address these widespread misconceptions regarding obesity, to destigmatize, and in the process develop a more compassionate approach, and one that encourages rather than stymies healthy lifestyle change [80]. In this endeavor, public health strategies will play a role. Changes to our food environment would include healthier and more affordable food choices (particularly for those poorer members of society from lower socio-economic backgrounds), with plant-based and high-fibre products, combined with restricted availability of unhealthy and addictive UPFs. Our future living environments should be designed to optimize physical activity, with an appreciation for the emotional benefits of green surroundings. As a society, we need to learn to value and promote restful and sufficient sleep as a prerequisite for a healthy lifestyle (that in turn would help to mitigate against weigh gain and obesity). In essence, we need to shift our focus from individual choice towards effective environmental change. Ultimately, the key to the successful prevention of obesity lies in our environment, and particularly our food environment. For all their benefits, pharmacotherapies for obesity (and by implication, PCOS) will never become the solution to obesity, but rather a sticking plaster over a gaping wound caused by our obesogenic environment. We need to heal, not just dress, that wound. Author Contributions Thomas M Barber wrote the first draft. Puja Thadani, Elizabeth V Niven, Ioannis Kyrou, and Harpal S Randeva all contributed meaningfully towards the revised version of our manuscript, including input into its structure and content. Funding No funding or sponsorship was received for the publication of this article. Data Availability Data sharing is not applicable to this article as no datasets were generated or analyzed during the current study. Declarations Conflict of Interest Thomas M Barber, Puja Thadani, Elizabeth V Niven, Ioannis Kyrou, and Harpal S Randeva have nothing to disclose. Ethical Approval This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors. Footnotes Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Data Availability Statement Data sharing is not applicable to this article as no datasets were generated or analyzed during the current study.